Literature DB >> 24798745

Selective packaging of the influenza A genome and consequences for genetic reassortment.

Marie Gerber1, Catherine Isel1, Vincent Moules2, Roland Marquet3.   

Abstract

Influenza A viruses package their segmented RNA genome in a selective manner. Electron tomography, biochemical assays, and replication assays of viruses produced by reverse genetics recently unveiled molecular details of this mechanism, whereby different influenza viral strains form different and unique networks of direct intermolecular RNA-RNA interactions. Together with detailed views of the three-dimensional structure of the viral ribonucleoparticles, these recent advances help us understand the rules that govern genome packaging. They also have deep implications for the genetic reassortment processes, which are responsible for devastating pandemics.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Keywords:  RNA–RNA interactions; genetic reassortment; influenza A virus; packaging; supramolecular complex

Mesh:

Substances:

Year:  2014        PMID: 24798745     DOI: 10.1016/j.tim.2014.04.001

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  71 in total

Review 1.  Mechanisms and consequences of diversity-generating immune strategies.

Authors:  Edze R Westra; David Sünderhauf; Mariann Landsberger; Angus Buckling
Journal:  Nat Rev Immunol       Date:  2017-08-07       Impact factor: 53.106

2.  Packaging of the Influenza Virus Genome Is Governed by a Plastic Network of RNA- and Nucleoprotein-Mediated Interactions.

Authors:  Hardin Bolte; Miruna E Rosu; Elena Hagelauer; Adolfo García-Sastre; Martin Schwemmle
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus.

Authors:  Isabel Wendel; Dennis Rubbenstroth; Jennifer Doedt; Georg Kochs; Jochen Wilhelm; Peter Staeheli; Hans-Dieter Klenk; Mikhail Matrosovich
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

4.  Heterologous Packaging Signals on Segment 4, but Not Segment 6 or Segment 8, Limit Influenza A Virus Reassortment.

Authors:  Maria C White; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

5.  Development and Characterization of a Reverse-Genetics System for Influenza D Virus.

Authors:  Jieshi Yu; Runxia Liu; Bin Zhou; Tsui-Wen Chou; Elodie Ghedin; Zizhang Sheng; Rongyuan Gao; Shao-Lun Zhai; Dan Wang; Feng Li
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets.

Authors:  Mahmoud M Naguib; Reiner Ulrich; Elisa Kasbohm; Christine L P Eng; Donata Hoffmann; Christian Grund; Martin Beer; Timm C Harder
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

7.  Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.

Authors:  Andrew J Broadbent; Celia P Santos; Amanda Anafu; Eckard Wimmer; Steffen Mueller; Kanta Subbarao
Journal:  Vaccine       Date:  2015-12-02       Impact factor: 3.641

8.  Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles.

Authors:  Wen-Chi Su; Wen-Ya Yu; Shih-Han Huang; Michael M C Lai
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 9.  Implications of segment mismatch for influenza A virus evolution.

Authors:  Maria C White; Anice C Lowen
Journal:  J Gen Virol       Date:  2017-12-15       Impact factor: 3.891

10.  Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer.

Authors:  Kuang-Yu Chen; Emmanuel Dos Santos Afonso; Vincent Enouf; Catherine Isel; Nadia Naffakh
Journal:  PLoS Pathog       Date:  2019-10-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.